10-Q: Evolv Technologies Q3 2025: Revenue Surges, Net Loss Narrows

Evolv Technologies Holdings, Inc. reported a significant revenue increase in Q3 2025, driven by strong product and subscription growth, while narrowing its net loss and securing new debt financing.

Summary

• Total revenue for the three months ended September 30, 2025, increased 57% to $42.85 million, up from $27.36 million in the prior year period.
• Net loss significantly narrowed to $1.80 million for Q3 2025, compared to a net loss of $30.44 million for Q3 2024.
• Product revenue surged 588% to $9.24 million in Q3 2025, from $1.34 million in Q3 2024, primarily due to increased utilization of the purchase subscription model.
• Subscription revenue grew 27% to $22.69 million in Q3 2025, from $17.91 million in Q3 2024, driven by customer base growth and more active Evolv Express systems.
• Operating expenses decreased 14% to $29.90 million for Q3 2025, down from $34.96 million in Q3 2024, reflecting cost-cutting measures.
• Cash, cash equivalents, and marketable securities totaled $56.2 million as of September 30, 2025.
• The company secured a new $75.0 million Senior Secured Credit Facility with MidCap Financial Trust, with $30.0 million drawn as an Initial Term Loan as of September 30, 2025.
• Annual Recurring Revenue (ARR) was $117.2 million as of September 30, 2025, which is sufficient to satisfy minimum required ARR through December 31, 2027.
• The U.S. Department of Justice (DOJ) informed the company on August 7, 2025, that it is no longer the subject of a DOJ investigation.
• A settlement in principle of $15.0 million was reached for a class action lawsuit, with an estimated $14.0 million expected to be funded by the company's Directors and Officers insurance coverage.
• The company discontinued quoting under its distributor licensing model, shifting new hardware purchase quotes to its purchase subscription model.
• A non-exclusive contract manufacturing agreement was entered into with Plexus Corp. on November 5, 2025, aimed at enhancing scalability, geographic diversification, and cost savings.

Sentiment

Score: 7

Explanation: The company demonstrated strong revenue growth and a significant reduction in net loss, alongside positive cash flow from operations. Strategic moves like new financing and manufacturing partnerships are positive. However, ongoing material weaknesses in internal controls and legal proceedings, though partially settled, temper the overall sentiment.

Positives

• Total revenue increased by 57% for the three months ended September 30, 2025, reaching $42.85 million, demonstrating strong top-line growth.
• Net loss significantly narrowed to $1.80 million in Q3 2025, a 94% improvement from the $30.44 million net loss in Q3 2024.
• Product revenue experienced a substantial 588% increase to $9.24 million in Q3 2025, indicating strong customer adoption of the purchase subscription model.
• Subscription revenue grew 27% to $22.69 million in Q3 2025, reflecting continued expansion of the customer base and active system deployments.
• Operating expenses decreased by 14% in Q3 2025, from $34.96 million to $29.90 million, due to effective cost-cutting measures including a reduction in force.
• Cash flow from operating activities turned positive, with an inflow of $3.10 million for the nine months ended September 30, 2025, a significant improvement from the $34.06 million outflow in the prior year.
• Secured a new $75.0 million Senior Secured Credit Facility, providing $45.0 million in undrawn capital for future operational needs and growth.
• Annual Recurring Revenue (ARR) of $117.2 million as of September 30, 2025, exceeds the minimum required ARR through December 31, 2027, demonstrating strong recurring revenue performance.
• Reached a settlement in principle for the class action lawsuit for $15.0 million, with an estimated $14.0 million expected to be covered by D&O insurance, mitigating financial impact.
• The U.S. Department of Justice (DOJ) informed the company on August 7, 2025, that it is no longer the subject of a DOJ investigation, reducing regulatory uncertainty.
• Entered into a non-exclusive contract manufacturing agreement with Plexus Corp. on November 5, 2025, expected to enhance scalability, geographic diversification, and create long-term cost-saving opportunities.

Negatives

• The company continues to incur net losses, totaling $44.02 million for the nine months ended September 30, 2025, and expects to generate losses for the foreseeable future.
• Identified material weaknesses in internal control over financial reporting, which led to prior financial statement restatements and adjustments, and disclosure controls were not effective as of September 30, 2025.
• The public warrant liability increased, resulting in a $2.58 million loss in Q3 2025 and a $6.16 million loss for the nine months ended September 30, 2025, due to fair value adjustments.
• Interest income decreased from $0.63 million in Q3 2024 to $0.44 million in Q3 2025, primarily due to lower average balances in interest-bearing accounts.
• Gross profit margin for subscription revenue decreased from 59% in Q3 2024 to 52% in Q3 2025, partly due to a $1.9 million loss on disposal of leased equipment and $0.6 million in estimated field services costs.
• Gross profit margin for service revenue decreased from 77% in Q3 2024 to 70% in Q3 2025, partly due to $0.5 million in estimated field services costs and increased capitalized software amortization.
• Ongoing legal proceedings, including derivative lawsuits and an SEC investigation, continue to pose risks and are expected to incur legal and professional services expenses in future periods.
• The company's ability to utilize net operating loss carryforwards may be limited by ownership changes under Sections 382 and 383 of the Internal Revenue Code.

Risks

• Material weaknesses in internal control over financial reporting could lead to future misstatements, revisions, or restatements, and adversely affect financial reporting accuracy and timeliness.
• Failure to prepare and timely file periodic reports with the SEC limits access to public markets for raising debt or equity capital.
• The company has a history of losses and may not achieve or maintain profitability in the future, as it expects costs to increase with business growth.
• Operating results may fluctuate due to various factors, including failure to close large volume customer sales, changes in sales mix, pricing, product cost, and margins.
• Failure to maintain successful relationships with reseller partners or their underperformance could limit the ability to market, sell, and distribute products.
• Increases in component costs, long lead times, supply shortages, and changes in suppliers could disrupt the supply chain and adversely affect business, financial condition, and operating results.
• Delays in production, increases in prices charged by, or the loss of, a limited or sole source supplier (e.g., Columbia Tech, Plexus onboarding risks) could have an adverse effect.
• The ratable recognition of a substantial portion of revenue means downturns or upturns in sales may not be immediately reflected in operating results.
• Inability to compete effectively with new entrants and other potential competitors could adversely affect sales and profitability.
• Sales to government entities are subject to challenges and risks, including changes in fiscal policies, budgetary cycles, and extensive compliance requirements.
• Failure to maintain and enhance the brand or reputation as an industry leader could adversely affect business and operating results.
• Acquiring or investing in other companies or technologies in the future could divert management's attention, fail to meet expectations, result in dilution, or disrupt operations.
• Product failures or perceived failures to detect threats, or undetected errors/defects, could result in injury, loss of life, reputational harm, and liability claims.
• Loss of the DHS SAFETY Act Designation for the Evolv Express system could result in adverse reputational and financial consequences.
• The AI-based weapons detection for security screening market is new and evolving and may not grow as expected or may develop more slowly or differently than anticipated.
• Risks associated with the use of AI and machine learning in product development and operation, including ethical issues, errors, bias, discrimination, intellectual property infringement, and regulatory uncertainty.
• Inability to acquire new customers, sell additional products to existing customers, or retain existing customers could hinder revenue growth.
• Failure to anticipate market needs and enhance existing products or develop new products on a timely basis could impair competitiveness and revenue generation.
• Reliance on third-party technology and components; inability to obtain or maintain rights to this technology could harm the business.
• Use of open-source software could subject proprietary software to certain disclosure obligations, negatively affect product offerings, and lead to litigation.
• Products collect and store personal data, exposing the company to risks related to privacy, data protection, information security, and potential cybersecurity incidents.
• Failure to effectively expand, train, and retain qualified sales and marketing personnel could impede growth strategy.
• Dependence on the continued services and performance of senior management and other key employees, and the ability to successfully hire, train, manage, and retain qualified personnel.
• Inability to protect proprietary technology and intellectual property rights could substantially harm business and operating results.
• Assertions by third parties of intellectual property infringement or other violations could result in significant costs and harm to business.
• Confidentiality arrangements with employees and others may not adequately prevent disclosure of trade secrets and other proprietary information.
• Subject to government regulation and other legal obligations related to privacy, data protection, information security, and product marketing; actual or perceived failure to comply could harm the business.
• Operating results may be harmed if required to collect sales and use or other related taxes in jurisdictions where it has not historically done so.
• Failure to comply with applicable anti-corruption legislation, export controls, economic sanctions, and other governmental laws and regulations could result in fines and criminal penalties.
• Ongoing legal proceedings, claims, and investigations (including class action and derivative lawsuits, and SEC investigation) could result in substantial costs, liabilities, and diversion of management's attention.
• Risks related to the ability to utilize net operating loss carryforwards and research and development tax credit carryforwards to offset future taxable income or tax liabilities.
• May require additional capital to support business growth, which might not be available on acceptable terms, if at all.
• Existing and future debt obligations may adversely affect financial condition and future financial results, including through restrictive covenants.
• The market price of common stock and warrants has been highly volatile and may continue to be so, leading to potential investment losses.
• Certain warrants, earn-out shares, and contingently issuable founder shares are accounted for as liabilities/assets, and changes in their fair value could materially affect financial results.
• No intention to pay cash dividends for the foreseeable future, making capital appreciation the sole source of gain for investors.
• Future sales, or the perception of future sales, of common stock by existing security holders in the public market may cause the market price of securities to decline.
• Reported financial results may be adversely affected by changes in accounting principles generally accepted in the United States.
• Lack of research or negative reports from securities or industry analysts could cause stock price and trading volume to decline.
• Business operations are vulnerable to disruption due to natural or other disasters, including climate-related events, strikes, and other events beyond control.

Future Outlook

The company expects to continue to generate losses for the foreseeable future as it strategically invests in business growth. It anticipates improved inventory efficiency and commercial terms from the new contract manufacturing agreement with Plexus. License revenue from the Columbia Tech agreement is expected to reduce to zero over time, replaced by increased product revenue. General and administrative expenses are projected to remain at a lower level in Q4 2025. The company expects its current cash, cash equivalents, marketable securities, and available credit facilities to be sufficient to fund operating expenses and capital expenditure requirements for at least the next twelve months.

Management Comments

• "We expect to continue to generate losses for the foreseeable future."
• "We expect our cash, cash equivalents, and marketable securities of $56.2 million as of September 30, 2025, together with cash we expect to generate from future operations and our borrowing availability under our Senior Secured Credit Facilities, will be sufficient to fund our operating expenses and capital expenditure requirements for a period of at least twelve months and thereafter from the date of this Quarterly Report on Form 10-Q."
• "As we are in the growth stage of our business and operate in an emerging field of technology, we expect to continue to strategically and carefully invest in various areas of the business to support that growth."
• "We expect our general and administrative expenses to remain at this lower level in the fourth quarter of 2025."
• "We believe there are several key trends that are continuing to drive increased adoption of our solutions and growth in our sales, including (i) escalating gun violence, which has created stronger demand for security screening solutions for customers and prospects in our key vertical markets, (ii) customer acquisition activities which led to the addition of 62 new customers during the three months ended September 30, 2025, and (iii) the expansion of our existing customers' initial Evolv Express deployments to other venues and locations as well as expanding their fleet with our Evolv eXpedite offering."

Industry Context

The company operates in the new and evolving AI-based weapons detection for security screening market, which is experiencing increased demand due to escalating gun violence and a shift towards frictionless security screening experiences in various venues. The industry is characterized by a focus on digitally transforming visitor entry points. However, the market is competitive, with larger players and new entrants, and faces uncertainties regarding the rapid development of AI technology, ethical issues, and an unsettled, quickly developing regulatory framework for AI governance.

Management Changes

Corporate Governance

Legal Proceedings

• **Class Action Lawsuits**: Consolidated putative class action lawsuits alleging federal securities law violations related to product effectiveness and revenue recognition. A settlement in principle of $15.0 million was reached on August 5, 2025, with an estimated $14.0 million expected to be funded by D&O insurance.
• **Derivative Lawsuits**: The Massachusetts Derivative Action and the First Delaware Derivative Action (filed March 10, 2025) are stayed pending the outcome of the Class Action. A Second Delaware Derivative Action was filed on October 2, 2025, and subsequently stayed on November 7, 2025. These lawsuits allege breach of fiduciary duty, unjust enrichment, and other claims against current and former officers and directors.
• **FTC Investigation**: A settlement was reached on December 5, 2024, requiring the company to permit a limited cohort of school customers to cancel contracts (period closed March 30, 2025) and to comply with certain compliance and record-keeping obligations. No monetary relief was imposed.
• **SEC Investigation**: The company received a subpoena in February 2024 and subsequent requests for documents and information relating to certain aspects of its marketing practices and self-reported sales practices investigation. The company is cooperating with this ongoing investigation.
• **DOJ Investigation**: The company received a voluntary document request in November 2024. On August 7, 2025, the DOJ informed the company that it is no longer the subject of a DOJ investigation.

Related Party Transactions

• Original Equipment Manufacturer Partnership Agreement with Motorola Solutions, Inc.: Motorola, a former investor, sold Motorola-branded products based on the Evolv Express platform. Effective in the fourth quarter of 2024, Motorola is no longer considered a related party. There was no related party revenue for the three and nine months ended September 30, 2025.

Stakeholder Impact

• **Shareholders**: Potential for increased value due to strong revenue growth and reduced net losses, but ongoing risks from internal control weaknesses and legal proceedings could create volatility. Dilution risk exists from potential future capital raises.
• **Employees**: Impacted by reductions in force in January 2025 and May 2024. New hires in key accounting and revenue roles aim to strengthen internal capabilities.
• **Customers**: Benefit from new product offerings like Evolv eXpedite and second-generation Evolv Express systems. Some school customers were offered contract cancellations due to the FTC settlement.
• **Suppliers/Contract Manufacturers**: The new agreement with Plexus Corp. will diversify manufacturing, potentially shifting business away from the existing primary contract manufacturer, Columbia Tech, over time.
• **Creditors**: The new $75.0 million credit facility with MidCap Financial Trust provides significant liquidity but also imposes financial and operational covenants that must be met.

Next Steps

• Continue to strategically and carefully invest in various areas of the business to support growth.
• Monitor and evaluate all applicable provisions of the OBBBA and any potential future impact on consolidated financial statements.
• Evaluate the impact of ASU 2024-03, ASU 2025-05, and ASU 2025-06 on disclosures within the consolidated financial statements.
• Continue remediation efforts for identified material weaknesses in internal control over financial reporting, including designing and implementing new controls.
• Class Action Plaintiffs are ordered to file a motion for preliminary approval of the settlement by December 15, 2025.
• Onboarding of Plexus as a new contract manufacturer, with anticipated improved inventory efficiency and commercial terms.
• Continue to monitor cash flows and capital requirements associated with the transition to Plexus.
• Design and implement a new deal review policy and process, including enhanced certification by the Sales team of terms and conditions.
• Create and maintain formal accounting policies, procedures, and controls to achieve complete, accurate, and timely financial accounting, reporting, and disclosures.
• Design and implement information technology general controls for all relevant information systems.
• Make investments in technology platforms, including enhancing financial and human resources systems to further automate processes.

Key Dates

Recommendation

While Evolv Technologies demonstrated strong revenue growth and a significant reduction in net loss, indicating operational improvements and market traction, the company continues to face material weaknesses in internal controls and ongoing legal and regulatory scrutiny. The new debt facility provides liquidity, but long-term profitability remains uncertain as the company is still in a growth stage and expects future losses. The positive operational trends are balanced by the governance and compliance challenges, suggesting a 'hold' position until remediation efforts are fully effective and legal uncertainties are resolved.

Keywords

Security Technology, AI-powered Screening, Weapons Detection, Evolv Express, Evolv eXpedite, SaaS Subscription, Physical Security, Threat Detection, Corporate Governance, SEC Filings, Financial Performance, Risk Management, Supply Chain, Legal Proceedings, Capital Raise, Quarterly Report